Related Experiment Video
Updated: May 21, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Early clinical diagnosis of synchronous multiple primary lung cancer
Xinying Xue1, Qingliang Xue, Na Wang
1The Respiratory Diseases Department of the Chinese PLA General Hospital, Beijing 100853, P.R. China.
Oncology Letters
|June 29, 2012
Summary
Diagnosing synchronous multiple primary lung cancer (SMPLC) is challenging. Recognizing malignant characteristics in multiple lung lesions and performing separate biopsies are crucial for early detection and effective treatment of SMPLC.
Area of Science:
- Pulmonology
- Oncology
- Diagnostic Imaging
Background:
- Synchronous multiple primary lung cancer (SMPLC) presents diagnostic challenges, often mimicking metastatic disease.
- Early and accurate diagnosis is vital for appropriate patient management and improved outcomes.
Purpose of the Study:
- To identify clinical clues for diagnosing SMPLC, particularly in early stages.
- To differentiate SMPLC from metastatic lung cancer.
Main Methods:
- Retrospective analysis of medical records from 10 patients diagnosed with SMPLC.
- Review of chest computed tomography (CT) findings and tumor marker levels.
- Evaluation of auxiliary examinations for metastasis and performance of separate biopsies.
Main Results:
- All patients exhibited two distinct pulmonary lesions with malignant characteristics on CT scans.
- Elevated tumor markers were observed in only two patients, indicating limited diagnostic utility.
- Absence of metastasis in other physical sites supported the diagnosis of SMPLC.
- Separate staging and tailored treatment based on individual tumor stages benefited patients.
Conclusions:
- Malignant characteristics of multiple pulmonary lesions are key indicators for SMPLC diagnosis.
- Tumor marker levels are unreliable for detecting SMPLC.
- Prompt separate biopsies and staging are essential for timely and effective treatment of SMPLC.
